Last updated on February 2019

Facilitated Immunoglobulin Administration Registry and Outcomes Study (FIGARO)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Secondary Immune Deficiency | Primary Immunodeficiency
  • Age: - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patient has received/will receive at least 1 HyQvia infusion for PID or SID
  • Patient has an indication for chronic immunoglobulin treatment
  • Patient is likely available for long-term documentation
  • Patient provides informed consent for documentation

Exclusion Criteria:

  • No explicit exclusion criteria apply.

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.